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ABSTRACT This study provides evidence of a novel function for mitochondrial creatine kinase (MtCK) and nucleoside
diphosphate kinase (NDPK-D). Both are basic peripheral membrane proteins with symmetrical homo-oligomeric structure,
which in the case of MtCK was already shown to allow crossbridging of lipid bilayers. Here, different lipid dilution assays clearly
demonstrate that both kinases also facilitate lipid transfer from one bilayer to another. Lipid transfer occurs between liposomes
mimicking the lipid composition of mitochondrial contact sites, containing 30 mol % cardiolipin, but transfer does not occur when
cardiolipin is replaced by phosphatidylglycerol. Ubiquitous MtCK, but not NDPK-D, shows some speciﬁcity in the nature of the
lipids transferred and it is not active with phosphatidylcholine alone. MtCK can undergo reversible oligomerization between
dimeric and octameric forms, but only the octamer can bridge membranes and promote lipid transfer. Cytochrome c, another
basic mitochondrial protein known to bind to anionic membranes but not crosslinking them, is also incapable of promoting lipid
transfer. The lipid transfer process does not involve vesicle fusion or loss of the internal contents of the liposomes.
INTRODUCTION
Morphological analysis of mitochondria with different
methods revealed connections between the outer andperipheral
inner membranes of mitochondria, the so-called contact sites,
e.g., in chemically ﬁxed mitochondria where the intermem-
brane space is enlarged (1), as jumps in the fracture planes of
freeze-fractured mitochondria (2), or in three-dimensional
electron tomography (3). These contacts fulﬁll various func-
tions, like the import of mitochondrial precursor proteins (4),
the channeling of high-energy phosphates from mitochondria
to the cytosol (5), and the formation of the mitochondrial
permeability transition pore that is involved in apoptotic
signaling (6). Contact sites are regulated, dynamic structures,
since their number depends on themetabolic activity of the cell
(7). Because of the close propinquity of the two membranes,
these contact sites would be expected to favor interbilayer
transfer of lipids. Two oligomeric kinases located at a speciﬁc
type of contact sites, and probably contributing to their for-
mation are the mitochondrial isoenzymes of creatine kinase
(MtCK) and mitochondrial isoform of nucleotide diphosphate
kinase (NDPK-D) (8–10). In this work, we have studied
whether these kinases are able to facilitate lipid transfer
between membranes, as this could be a novel functional
property of the twoproteins. Transfer of lipids between bilayers
is only known to be facilitated by speciﬁc lipid transfer proteins
(11–13). There is a report indicating that t-Bid has lipid transfer
activity (14), but this is suggested to be a result of its structural
similarity to other lipid transfer proteins (15). Such lipid
transfer is known to occur in intact mitochondria, e.g., during
apoptosis, in the form of cardiolipin transfer from the inner to
the outer mitochondrial membrane (16–19).
Creatine kinase (CK) plays an important role in forming a
circuit or shuttle for phosphocreatine between microcompart-
ments in the cell (20). Most vertebrate tissues express two
isoforms of CK, a dimeric cytosolic and a mostly octameric
mitochondrial isoform (MtCK). The latter occurs either as the
sarcomeric form in striated muscle, or as the ubiquitous form
(uMtCK) in most other tissues including brain and kidney
(21). MtCK undergoes concentration-dependent reversible
oligomerization between octameric and dimeric forms with
octameric uMtCK dissociating 23–24 times slower, com-
pared with the other mitochondrial isoform (22). Mainly the
octameric form shows fast binding to anionic phospholipids,
while much slower binding of dimers probably occurs
through octamerization at the membrane surface (23). Sim-
ilarly, mainly octameric MtCK mediates intermembrane
contact between liposomes of isolated inner and outer mito-
chondrial membranes. This membrane binding is largely
stabilized by electrostatic interactions with anionic lipids
(24). The crystal structure of both octameric MtCKs were
determined (25,26) and it was subsequently demonstrated that
several C-terminal lysine residues of the protein facilitated
this interaction (27). Using surface plasmon resonance (28,29),
MtCK membrane binding was shown to occur already at 16%
cardiolipin and to involve two independent binding sites with
similar afﬁnities (80–100 nM). The basic mitochondrial
protein, cytochrome c, which we also use in this work, also
bound to the immobilized lipid under these conditions.
Binding of the MtCK to lipid is accompanied by a small
conformational change in the protein as well as by a change in
the ordering of the lipids (30).
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MtCK is localized between the inner and outer mitochon-
drial membranes, the so-called peripheral intermembrane
space, as well as along the cristae membranes (31), mostly
bound to cardiolipin at the inner membrane and enriched in
contact sites (32). Recent evidence indicates that uMtCK in-
duces and stabilizes contact sites between inner and outer
mitochondrial membranes (33). Liver mitochondria, mainly
devoid of MtCK, were compared to those from transgenic
mice expressing uMtCK in their livers. Only transgenic mito-
chondria showed an increased number of contact sites as
revealed by electron microscopy, and an improved resistance
against lysis by detergent or oxidative agent.
NDPK-D is part of a large family of hexameric isoen-
zymes that are encoded by different nm23 genes and exert
multiple functions in cellular energetics, signaling, prolifer-
ation and differentiation. Although NDPK activity was
reported in mitochondria with different localization depend-
ing on the species or the organ (34) and was located in var-
ious submitochondrial fractions, only NDPK-D has a
mitochondrial targeting sequence and has been unambigu-
ously localized as bound to the inner mitochondrial mem-
brane, in particular to contact sites (10). NDPK-D shows
similar properties to uMtCK, insofar as it also binds to
anionic phospholipids like cardiolipin and is capable of cross-
linking two lipid bilayers, probably due to the symmetry of
its hexameric structure (M. Tokarska-Schlattner, U. Schlatt-
ner, andM.-L. Lacombe, unpublished data). However, unlike
uMtCK, NDPK-D remains hexameric at any protein con-
centration (35). There is particular interest in the products
from the nm23 gene family because they are involved in
tumor progression and metastasis (36). NDPK-D was found
to be overexpressed in a majority of gastric and colon cancers
(37), possibly linking NDPK-D to the development of tumors.
Interbilayer transfer of lipid between the inner and outer
membranes of mitochondria may play an important role in
the regulation and initiation of apoptosis. It is known that the
proapoptotic Bcl-2 proteins t-Bid and Bax will bind more
readily to membranes with exposed cardiolipin (38–41).
However, the major fraction of cardiolipin in cells is present
on the inner leaﬂet of the inner mitochondrial membrane
(42). Cardiolipin must ﬁrst become exposed to the outer
surface of the outer mitochondrial membrane to interact with
Bcl-2 proteins to maximally induce apoptosis. In fact, at least
with some forms of apoptosis, there is increased exposure of
cardiolipin at the mitochondrial surface (16–18). Such a trans-
fer has to include an exchange from the inner mitochondrial
membrane to the outer membrane, as well as transbilayer
diffusion in each of the two mitochondrial membranes. It has
been shown that Bcl-2 proteins themselves can accelerate
transbilayer diffusion of phospholipids (43,44). In addition, a
lipid transfer protein was shown to promote cytochrome c
release in isolated mitochondria, demonstrating a direct link
between lipid transfer and apoptosis (19). Finally, inter-
membrane cardiolipin transfer would also be essential for a
recently suggested regulation of the VDAC channel (45) in
the mitochondrial outer membrane and part of the contact
site complexes that often involve uMtCK and NDPK-D.
In this work we wish to determine if phospholipid transfer
is facilitated by proteins present in mitochondrial sites in
which the inner and outer mitochondrial membranes become
juxtaposed, i.e., by uMtCK and/orNDPK-D.With a lipid com-
position resembling that of mitochondrial contact sites (46),
in which each of these two proteins can bridge vesicles and
allow their close approach, we ﬁnd a marked increase in the
rate of phospholipid transfer facilitated by uMtCK and
NDPK-D, without concomitant fusion of the vesicles. The
transfer process is speciﬁc for the oligomeric state of the
protein that can bridge membranes and does not occur with
the dimeric form of uMtCK.
EXPERIMENTAL PROCEDURES
Materials
Unlabeled phospholipids, as well as n-(lissamine Rhodamine B sulfonyl)
phosphatidylethanolamine (Rh-PE) and n-(7-nitro-2,1,3-benzoxadiazol-4-yl)
phosphatidylethanolamine (NBD-PE), were purchased from Avanti Polar
Lipids (Alabaster, AL). TheCL is the tetraoleoyl form. The tetraoleoyl form is
abundant in human lymphoblasts and in yeast (47). All other ﬂuorescently-
labeled phospholipids were from Molecular Probes (Eugene, OR). The
structures of the ﬂuorescently-labeled phospholipids used in this work are
shown in Fig. 1. Poly-L-lysine (21 kDa) and cytochrome cwere obtained from
Sigma (St. Louis, MO). Recombinant mature uMtCK was expressed and
puriﬁed as described earlier (26). For some experiments, the ﬁnal preparation
of uMtCK was concentrated fourfold using a 10 kDa cutoff Microcon
centrifugal ﬁlter YM-10 (Millipore, Billerica, MA). It was found that lipid
transfer assays in which uMtCK was added from a more concentrated pro-
tein solution exhibited higher activity. Recombinant NDPK-D, missing the
mitochondrial targeting sequence (ﬁrst 33 amino acids) and fused to a
hexahistidine tag,was expressed and puriﬁed as described inMilon et al. (10).
Preparation of large unilamellar vesicles (LUVs)
Lipids were codissolved in chloroform/methanol (2:1, v/v). The solvent was
then evaporated under a stream of nitrogenwith constant rotation of a test tube
so as to deposit a uniform ﬁlm of lipid over the bottom third of the tube. Last
traces of solvent were removed by placing the tube under high vacuum for 3 h.
The lipid ﬁlm was then hydrated with buffer, as indicated for speciﬁc ex-
periments. Large unilamellar vesicles (LUVs)weremade from this suspension
by ﬁve freeze-thaw cycles and extruded 10 times through two polycarbonate
ﬁlters with either 50- or 200-nm pore size, in a Lipex barrel extruder under
nitrogen pressure (Lipex Biomembranes, Vancouver, BC, Canada). Vesicles
were kept on ice under Argon gas and used within a few hours of preparation.
Lipid concentration was determined with the phosphate assay of Ames (48).
BODIPY-FL-C5-HPC transfer assay
The transfer of BODIPY-labeled lipid between donor and acceptor vesicles
was monitored by a lipid dilution assay based on the relief of self-quenching
similar to that recently described by Esposti and co-workers (14).
Donor vesicles were prepared from lipid ﬁlms containing 2-(4,4-diﬂuoro-
5,7-dimethyl-4-bora-3a, 4a-diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-
sn-glycero-3-phosphocholine (BODIPY-FL-C5-HPC)/1-palmitoyl-2-oleoyl
phosphatidylethanolamine (POPE)/cardiolipin (CL) in equimolar amounts
and were made into 50-nm diameter LUVs by extrusion. Acceptor LUVs
were made of an equimolar mixture of 1-palmitoyl-2-oleoyl phosphatidyl-
choline (POPC)/POPE/CL and made into 200-nm diameter LUVs. The LUV
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were prepared in 10 mMHEPES, 1 mM b-mercaptoethanol, pH 7.0 and kept
in ice under nitrogen, in the dark, before use. The assay was carried out in
1 cm 3 1 cm path-length disposable acrylic ﬂuorimeter cuvettes at 25C,
with magnetic stirring using an SLM-Aminco Bowman AB-2 spectroﬂu-
orimeter (Urbana, IL). Donor vesicles were added to 2 mL of 10 mMHEPES
and 1 mM b-mercaptoethanol, pH 7.0 to a lipid concentration of 300 nM.
After equilibration for 30 s, acceptor LUVs were added to a concentration of
4 mM. Fluorescence emission was measured at 515 nm, using an excitation
wavelength of 485 nm and a 4 nm bandpass in both excitation and emission.
After a few hundred seconds, octameric uMtCK was added as a solution that
had been dialyzed against 10 mMHEPES and 1 mM b-mercaptoethanol, pH
7 and ﬂuorescence recording was continued. To obtain the ﬂuorescence
intensity corresponding to 100% transfer, 20 mL 20% Lubrol PX was added
as a detergent to the mixture in the cuvette.
General procedure for other lipid transfer assays
We describe here the elements that are common to the various lipid mixing
assays used in the course of this study. Details speciﬁc for each of the
methods are given subsequently. The lipid composition of both donor and
acceptor vesicles was POPC/POPE/CL (1:1:1). Donor vesicles with ﬂuo-
rescent label were extruded to make 50-nm diameter LUV (or sonicated to
make SUV in some pyrene label assays) and the acceptor vesicles extruded
to 200 nm diameter LUV. The donor LUVs were placed in 2 mL of 10 mM
HEPES, 0.1 mM EDTA, and 0.14 M NaCl, pH 6.9 (HEPES buffer) at 37C
with magnetic stirring. In experiments where Ca21 was required, the buffer
composition was calculated so that in the presence of 0.1 mM EDTA and
1 mMMg21 there would be 200 nM free Ca21 (HEPES-Ca21 buffer) using
the program WINMAXC v2.50 (Chris Patton, Stanford University). This
HEPES-Ca21 buffer still contains 10 mM HEPES, 0.1 mM EDTA, and 0.14
M NaCl, pH 6.9. LUVs were kept on ice, under Argon, in the dark. Labeled
donor vesicles were added to 2 mL HEPES buffer in the 1 cm 3 1 cm path-
length ﬂuorimeter cuvette, withmagnetic stirring, to give a ﬁnal lipid concen-
tration of 300 nM. After a few seconds equilibration, acceptor LUVs were
added (3 mM) and the ﬂuorescence intensity was recorded for a length of
time before and after addition of protein to the cuvette. Emission scans were
also performed before and after addition of protein. Experiments were re-
peated at least twice. Molarities were always calculated using a molecular
mass corresponding to the octamer for uMtCK and to the hexamer for
NDPK-D.
Octadecyl rhodamine B (R18) transfer assay
The octadecyl rhodamineB (R18) assay has been extensively used tomonitor
the fusion of envelopedviruses to targetmembranes (49).A solution ofR18 in
ethanol was added to the donor vesicles to give 10% R18 in the vesicles (the
ﬁnal concentration of ethanol in the 2 mL total volume in the cuvette was
0.1%). The mixture was subjected to an incubation period of several hours at
room temperature, under argon, with occasional gentle shaking to allow
incorporation of the label into the LUVs. The labeled liposomes were then
passed through a 1.5 3 25 cm column of Sephadex G-75 (Amersham
Biosciences, Piscataway, NJ), collecting the vesicles in the void volume. It
was found that almost all of the R18 had incorporated into the liposomes;
therefore, this last stepwas skipped in subsequent experiments. The excitation
wavelength was 565 nm and emission was 595 nm. Cutoff ﬁlters used were
550 nm in excitation and 570 nm in emission. A 4-nm bandpass in excitation
and in emission was used. A ﬂuorescence emission spectrumwas also run for
each sample, both before and after addition of protein. Controls in the absence
of acceptor LUVs were also run. The value for 100% transfer was obtained
with the addition of 20 mL 20% Lubrol PX followed by brief sonication or
by adding an amount of R18 to LUVs corresponding to the complete dilution
into donor plus acceptor vesicles (;1%).
Transfer of pyrene-labeled lipids
between liposomes
A lipid dilution assay, based on the loss of intermolecular excimer ﬂuores-
cence, was employed to measure lipid transfer (50,51). Donor vesicles were
made with 10 mol % of either 1-hexadecanoyl-2-(1-pyrenedecanoyl) (Pyrene)
phosphatidylcholine (PC), Pyrene phosphatidylethanolamine (PE), or Pyrene
phosphatidylglycerol (PG) incorporated into ﬁlms of POPC/POPE/CL (1:1:1)
or POPC/POPE/POPG (1:1:1) and made into SUVs or into 50 nm LUVs after
hydrationwithHEPES-Ca21 buffer, pH6.9. Acceptor vesicleswere unlabeled
200-nm LUVs of the same composition, but without the presence of pyrene-
labeled lipid. Fluorescence was recorded for a few seconds, and then protein
was added. The decrease in excimer ﬂuorescence, that occurred only after
protein was added, was followed over time. The excitation wavelength was
344 nm and emission was monitored as a ratio (Ie/Im) of the intensities of
excimer emission at 476 nm (Ie) and monomer emission at 397 nm (Im). A
4-nm bandpass was used in both excitation and emission. In addition, a
FIGURE 1 Structures of ﬂuorescently labeled lipids used in this work. (A)
BODIPY-FL-C5-HPC; (B) R18; (C) Rh-PE; (D) NBD-PE; and (E) generic
pyrene phospholipid, where R completes the headgroup of PC, PE, or PG.
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wavelength emission scan was performed before and after protein addition.
Runswere repeated in the absence of acceptor to assess the effect of the protein
on the ﬂuorescence properties of the pyrene lipid in the absence of net lipid
transfer. A constant stream of nitrogen was passed continually through the cell
compartment to prevent oxygen quenching of pyrene.
A calibration curve was established for the dependence of Ie/Im on the
mol fraction of pyrene-labeled lipid in the membrane. This standard curve
was then used to correlate the observed Ie/Im with the extent of transfer of
labeled lipid, assuming that the labeled lipid in the inner monolayer does not
get transferred within the time of the experiment.
Fluorescence resonance energy transfer
(FRET)-based lipid transfer assay
The resonance energy transfer assay of Struck et al. (52) was used. Two
populations of LUVs were prepared, one unlabeled and one labeled. The 50-
nm diameter donor vesicles were labeled with 1 mol % each of NBD-PE and
Rh-PE. The excitation wavelength was 450 nm and emission 530 nm, with a
4-nm bandpass in excitation and emission, and a 500-nm cutoff ﬁlter in the
emission path. Fluorescencewas recordedbefore and after addition of protein,
as a function of time. An emission scan was performed for each run, before
and after addition of protein.
Leakage studies with ANTS/DPX
Leakageof aqueous contents from liposomeswas determinedusing theANTS-
DPX assay (53). Lipid ﬁlms of POPC/POPE/CL (1:1:1) were hydrated with
12.5 mMANTS, 45mMDPX, and 10mMHEPES, at pH 6.9. The osmolarity
of this solution was adjusted to 300 mOsm with NaCl using a cryoosmometer
(Advanced Model 3MOplus Micro-Osmometer, Advanced Instruments,
Norwood, MA). LUVs of 50-nm diameter were prepared by extrusion as
described above. The LUVs were then passed through a Sephadex G-75
column (AmershamBiosciences) previously equilibratedwith the samebuffer,
to remove unentrapped dyes. Phosphate analysis was then carried out with the
method ofAmes (48). A second population of LUVs of 200-nm diameterwere
prepared with the same lipid composition suspended in 10 mM HEPES, 0.1
mM EDTA, and 0.14 M NaCl, pH 6.9 adjusted to 300 mOsm, but without
ﬂuorescent probes. LUVs were kept on ice under nitrogen, in the dark, before
measurement. The ﬂuorescence measurements were performed in 2 mL of
the HEPES buffer, pH 6.9, in a 1 cm 3 1 cm path-length quartz cuvette
equilibrated at 37C with magnetic stirring. When Ca21 was required, the
HEPES-Ca21 buffer, pH 6.9, was used. Aliquots of LUVs were added to the
cuvette to a ﬁnal lipid concentration of 2.5 mMLUVs with entrapped dye and
25 mM unlabeled LUVs. The ﬂuorescence was recorded as a function of time
with an SLM Aminco Bowman Series II spectroﬂuorimeter, using an
excitation wavelength of 344 nm and an emission wavelength of 544 nmwith
an 8-nm bandwidth slit in excitation and 4 nm in emission. A 500-nm cutoff
ﬁlter was placed in the emission path. The value for 100% leakage was
obtainedby adding 20mLof a 20%Lubrol PXsolution to the cuvette, followed
by brief sonication. Measurements were performed in duplicate.
Quasi-elastic light scattering (QUELS)
The size distributions of the LUVs were determined with quasi-elastic light
scattering using a Brookhaven Model B1 9000AT digital correlator equipped
with a BI-200sm goniometer, version 2.0 and a BI-900AT Digital Correlator
System (Brookhaven, Holtsville, NY). The temperature of the sample
compartmentwasmaintained at 25Cwith ﬂuid circulating from a thermostated
bath. LUVs of 50- and 200-nmdiameters and of the same lipid composition and
concentrations as used in transfer assays were mixed in the cuvette. The
scattering from the sample was measured at 90 over a period of a fewminutes.
Size distribution was calculated with a nonnegatively constrained least-squares
algorithm, with software provided by the instrument manufacturer.
RESULTS
BODIPY-FL-C5-HPC lipid mixing assay
with uMtCK
The acyl chain-labeled zwitterionic probe BODIPY-FL-C5-
HPC (Fig. 1 A) was incorporated into the donor vesicles
together with POPE and CL, all three lipids being at equi-
molar amounts. A similar assay based on the relief of self-
quenching was used previously by Esposti (14) to study
interbilayer lipid transfer promoted by the pro-apoptotic
protein, tBid. Application of this assay to our particular set of
conditions resulted in a high spontaneous rate of lipid transfer
in the presence of acceptor vesicles (Fig. 2). Nevertheless, a
signiﬁcant additional increase in the rate of lipid dilution was
clearly observed after the addition of octameric uMtCK, a
basic protein of the mitochondrial intermembrane space
known to crosslink membranes. A control in the absence of
acceptor vesicles showed that there was no direct effect of
uMtCK on the ﬂuorescence of the probe (not shown).
R18 lipid mixing assay with uMtCK
Dilution of R18, a cationic amphiphile (Fig. 1 B), to relieve
self-quenching can be a result of transfer between membranes
(54), although for many assay conditions the exchange pro-
cess is small (55,56). In the absence of membrane fusion R18
has already been used in some systems to assay lipid exchange
processes (57,58). We have found that in our assay system
R18 did not give a spontaneous rate of lipid transfer in the
absence of protein. Addition of octameric uMtCK caused a
marked increase in the rate of R18 lipid transfer. Without
protein, no lipid transfer was seen. In this assay, the uMtCK is
added into the assay cuvette from a protein stock solution of a
concentration above 4 mg/mL. The protein is therefore in its
octameric form, but once diluted into the cuvette it would
FIGURE 2 Phospholipid transfer assay using BODIPY-FL-C5-HPC and
uMtCK. The assay mixture contained 300 nM donor vesicles composed of
BODIPY-FL-C5-HPC/POPE/CL in 10 mM HEPES buffer, 1 mM mercap-
toethanol, pH 7.0. (1) Addition of 4 mM acceptor vesicles of POPC/POPE/
CL (1:1:1) at 30 s (arrow) shows spontaneous lipid transfer; (2) Sup-
plementation with additional 300 nM octameric uMtCK at 300 s (arrow)
further increases the rate of lipid transfer.
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dissociate into dimers over time. However, this is a slow
process exceeding the time required for lipid transfer (23). As
a control, we ﬁrst allowed uMtCK to dissociate into dimers by
dilution and incubation overnight in the refrigerator before
beingmixedwith the liposomes.When uMtCK is added in the
predissociated dimeric form it is almost completely inactive in
promoting transfer of R18 lipid (not shown), in contrast to the
case in which the protein is added in the octameric form from
concentrated solution. It is also known that uMtCK binds
anionic lipids more strongly at low ionic strengths (25). How-
ever, we observed that at very low ionic strengths the rate of
transfer is very small. This low transfer ofR18 lipid at low ionic
strengthmay be the result of electrostatic repulsion keeping the
two liposomes apart as well as to changes in surface pH or
changes in the nature of the binding of uMtCK.This behavior is
similar to that reported previously with myelin basic protein
(59). Consequently, most of the assays were carried out at 140
mMNaCl. Addition of 1mMMg21 subsequent to the addition
of uMtCK caused a more rapid rate of R18 transfer.
Role of divalent cations in the exchange process
It has been suggested that Ca21 plays an important role in
localizing uMtCK to mitochondrial contact sites (60). We
observed that millimolar concentrations of Ca21 markedly
stimulated the transfer of R18 lipid in the presence of uMtCK
(data not presented). Mg21 can also bind to anionic lipids
and reduce the concentration of Ca21 required for certain pro-
cesses. Unlike Ca21, physiological concentrations of Mg21
are in the millimolar range and not markedly regulated. We
therefore investigated if much lower concentrations of Ca21
in the presence of Mg21, which is closer to physiological
situations, could still have some stimulatory effect in lipo-
somal assays. A dose response curve showed that the extent
of R18 lipid exchange is strongly dependent on the amount
of octameric uMtCK added (Fig. 3 A). An analysis of these
curves gives a reasonable ﬁt as a ﬁrst-order rate process with
half-times of 90, 120, and 80 s for 200, 100, and 50 nM
uMtCK, respectively. The calculated extent of maximal
transfer is 32, 23, and 8% for the three concentrations of
uMtCK used. When utilizing a HEPES buffer with EDTA,
adjusted to contain 200 nM free Ca21, synergistic effects in
the promotion of lipid transfer were observed upon the
addition of 1 mM Mg21 (Fig. 3 B, curves 1 and 2), and thus
this buffer composition was used throughout this study.
R18 lipid mixing assay with NDPK-D
Another oligomeric basic kinase of the mitochondrial
intermembranous space is hexameric NDPK-D, which can
also bridge the two mitochondrial membranes. Like uMtCK,
NDPK-D also promotes the exchange of R18 lipid (Fig. 3 C),
which is enhanced by a HEPES-Ca21 buffer in the presence
of 1 mMMg21 (Fig. 3 C, curve 3). The hexameric form has a
FIGURE 3 Transfer of R18 lipid promoted by uMtCK or NDPK-D at
37C. (A) Dose response curve for uMtCK added at 40 s (arrow) together
with 1 mM Mg21 to a HEPES-Ca21 buffer pH 6.9. Labeled donor vesicles
with a 50-nm diameter, of composition POPC/POPE/CL (1:1:1) at 300 nM
concentration, were mixed in cuvette with 3 mM of 200 nm diameter
acceptor LUVs, of the same lipid composition. (1) 200 nM uMtCK; (2) 100
nM uMtCK; (3) 50 nM uMtCK; (4) No protein added. (B) Conditions for
transfer promoted by uMtCK in HEPES-Ca21 buffer, pH 6.9. (1) 1 mM
Mg21 added at 40 s together with 100 nM uMtCK; (2) Protein added at
40 s and 1 mMMg21 added at 420 s (see arrow); (3) Removal of CL in donor
vesicles. Donor vesicle composition here is POPC/POPE (1:1). Mg21 added
at 40 s together with uMtCK; (4) Control without protein, but with donor
and acceptor vesicles. Mg21 added at 40 s. (C). Transfer of R18 lipid
promoted by 100 nM NDPK-D, at 37C. (1) Protein added at 40 s
(arrow), no Mg21 added to a HEPES-Ca21 buffer (containing 0.14 M
NaCl), pH 6.9. (2) NDPK-D added at 40 s with 1 mM Mg21, in 10 mM
HEPES, 0.14 M NaCl, pH 6.9. (3) NDPK-D added at 40 s together with
1 mM Mg21, in a HEPES-Ca21 buffer, pH 6.9.
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high stability, and low concentrations of the protein are sufﬁ-
cient for promoting the transfer.
Role of CL in lipid transfer process
Cardiolipin is a marker lipid for mitochondria. This lipid,
present predominantly in the inner membrane, is also
enriched in contact sites and its biophysical properties in
model membranes are modulated by divalent cations. We
therefore determined if CL affected the transfer of lipid
promoted by uMtCK or by NDPK-D. When we changed the
lipid composition of the liposomes in the R18 lipid transfer
assay from POPC/POPE/CL (1:1:1) to POPC/POPE/
CL (41.5:41.5:17.5), lipid transfer was essentially completely
blocked, even in the presence of 200 nM Ca21 and 1 mM
Mg21 (not shown). The lower CL concentration of 17.5% is
just above the 16% required for the protein to bind to
membranes (29), while the higher concentration corresponds
to the estimated amount of CL in contact sites (46). We also
removed CL from the donor vesicles, making them with the
lipid composition POPC/POPE (1:1), while retaining the
composition of the acceptor vesicles as POPC/POPE/CL
(1:1:1) (Fig. 3 B, curve 3). Again, lipid transfer was
completely blocked. Finally, we replaced CL with POPG
to make both donor and acceptor vesicles of POPC/POPE/
POPG (1:1:1); again lipid transfer was blocked (not shown).
Membrane fusion and aqueous content leakage
with uMtCK and NDPK-D
As a control for membrane fusion, we used a lipid dilution
assay based on FRET between Rh-PE and NBD-PE. There
was no lipid mixing measured by this assay with either
uMtCK or with NDPK-D in the presence or absence of 1 mM
Mg21 and 200 nMCa21 (Fig. 4, A and B). This assay can also
detect lipid transfer, but it does not occur with these
headgroup-labeled lipids.
We also determined the ability of uMtCK or NDPK-D to
induce leakage of aqueous contents with LUV of POPC/
POPE/CL (1:1:1) in the presence of Ca21 and Mg21. No
leakage of aqueous contents was detected using the ANTS/
DPX dequenching assay with either uMtCK (Fig. 4 C) or
with NDPK-D (Fig. 4 D). This ﬁnding provides further evi-
dence against R18 lipid dilution being the result of mem-
brane fusion, since protein or peptide-promoted membrane
fusion in model liposome systems is always accompanied by
some leakage of aqueous contents. In addition, this ﬁnding
also eliminates the possibility that probe transfer was a result
of bilayer destabilization and vesicle collapse.
Comparison with other basic proteins
Comparison of uMtCKwas made with another mitochondrial
protein that associates with anionic lipids, that is cytochrome
c, as well as the basic polypeptide, poly-L-lysine. In contrast
to both uMtCK and NDPK-D (Fig. 4, A and B), poly-L-lysine
causes the promotion of membrane fusion as assessed by the
ﬂuorescence resonance energy transfer (FRET) assay (Fig. 5
A, curve 1), thus eliminating the possibility that association of
the positive charge with a negative probe prevented lipid
exchange. Cytochrome c was unable to produce fusion of
vesicles (Fig. 5 A, curve 2). It had also been shown that a syn-
thetic peptide corresponding to the presequence of cyto-
chrome c oxidase subunit IV from yeast inserted itself into
lipidmonolayers and strongly promoted the formationof close
contacts with large unilamellar lipid vesicles present in the
FIGURE 4 (A) No fusion observed with
Rh-PE/NBD-PE FRET assay. (1) 100 nM
uMtCK. (2) 100 nM NDPK-D added with
1 mM Mg21 at 25 s (arrow) to donor and
acceptor vesicles of composition DOPC/
DOPE/CL (1:1:1). LUVs as described in
Experimental Procedures. (B) Fluorescence
emission scans for the assay shown in panel
A, before (black curve) and after (red curve)
addition of 100 nM NDPK-D. (C). Leakage
of ANTS/DPX assay carried out in 10 mM
HEPES, 0.14 M NaCl, pH 6.9, as described
in Experimental Procedures. (Black curve)
LUVs alone. (Red curve) 120 nM uMtCK
added at 20 s (arrow). (Blue curve) 240 nM
uMtCK added at 20 s. The value for 100%
release was obtained by adding 20 mL of a
20% Lubrol PX solution to the cuvette at
300 s. (D). Leakage assay carried out in
HEPES-Ca21 buffer. 1 mMMg21 added at
40 s (arrow). (Black curve) LUVs alone.
(Red curve) 100 nM uMtCK added at 25 s.
(Blue curve) 100 nM NDPK-D added at
25 s. For 100% release, 20 mL of 20%
Lubrol PX was added at 220 s.
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subphase, a property which was also speciﬁc for cardiolipin,
resulting in the ﬂow of lipids from the vesicles to the mono-
layer (61). Although cytochrome c binds to anionic lipids, it
does not cross-link vesicles and it does not promote the
exchange of R18 lipid, either in the presence (Fig. 5 B, curve
2) or absence (not shown) of divalent cations. In comparison,
the highly basic polypeptide, poly-L-lysine, that is known to
aggregate and destabilize liposomes (62), does promote
transfer of R18 lipid (Fig. 5 B, curve 1).
Speciﬁcity of lipids that can be exchanged
Lipid dilution assays were also carried out with several lipids
that were labeled with pyrene on the acyl chain. This assay
monitors the transfer of diacyl phospholipids labeled on the
acyl chain and it can be readily applied to several commer-
cially available pyrene-labeled phospholipids. It is based on
the loss of intermolecular excimer emission because of lipid
dilution. Excimers form because of collision between two
pyrene moieties, one in the excited state and the other in the
ground state. Fluorescence emission from an excimer occurs
at a different wavelength than from the monomer. In our
assay, the pyrene-labeled lipid was incorporated into the lipid
ﬁlm and hence was on both monolayers of the extruded
vesicle. This is different from the R18 assay, in which the
more soluble probe was introduced to preformed liposomes
and hence was only in the outer monolayer. A standard curve
comparing the Ie/Im ratio observed for a series of liposomes
containing different mol fractions of pyrene-labeled lipid was
established, taking into account the fact that the label on the
inner monolayer could not undergo exchange without cross-
ing the bilayer. In addition, protein effects on the Ie/Im ratio
were controlled bymeasuring changes to donor vesicles in the
absence of acceptor vesicles.
The same conditions as for the R18 assay (i.e., POPC/
POPE/CL vesicles), except for the change in probe, were
utilized. Lipid exchange promoted by uMtCKwas very depen-
dent on the presence of divalent cations and showed speciﬁc-
ity for PE and PG over PC (Fig. 6). There was little effect of
FIGURE 5 (A) Rh-PE/NBD-PE FRET assay. (1) 100 nM poly-L-lysine;
(2) 100 nM cytochrome c; (3) control without protein and with 1 mMMg21
added at 25 s (arrow). Vesicles as described in Experimental Procedures. (B)
R18 lipid transfer assay. (1) 100 nM poly-L-lysine; (2) 100 nM cytochrome
c. LUVs as described in Fig. 3 A. The assay was carried out in a HEPES-
Ca21 buffer at pH 6.9 and 37C; proteins were added together with 1 mM
Mg21 at 25 s (arrow). No effect of Mg21 was detected when the assay was
repeated in the absenceofMg21. At 320 s, 20mLof20%Lubrol PXwas added.
FIGURE 6 (A) Dilution of pyrene-labeled lipids with uMtCK. LUVs as
described in Fig. 3Abut containingpyrene labels. The assaywas carried out in
HEPES-Ca21 buffer at pH 6.9 and 37C. 100 nM uMtCK was added at 30 s
(arrow). Mg21was added at 240 s (arrow). (Black curve) Control with donor
vesicles containing Pyrene PG but without acceptor vesicles (controls for
other pyrene lipids without acceptor were similar and are not shown). (Blue
curve) Ie/Im in the presence of 10 mol % Pyrene PC. (Red curve) Ie/Im in the
presence of 10 mol % Pyrene PE. (Green curve) Ie/Im in the presence of 10
mol % Pyrene PG. (B) Percentage transfer in the outer monolayer calculated
from a standard curve constructed with different mol % of pyrene lipids.
132 Epand et al.
Biophysical Journal 92(1) 126–137
the uMtCK on the probe ﬂuorescence in the absence of accep-
tor vesicles. With NDPK-D, there was less transfer of pyrene
lipid and no speciﬁcity in the lipid transferred (not shown).
The effect of NDPK-D on probe ﬂuorescence was not due to
direct effects of the protein on the probe distribution in the
membrane or its mobility, since controls lacking acceptor
vesicles did not show any decrease in Ie/Im over time. In
addition, ﬂuorescence emission scans before and after addi-
tion of NDPK-D revealed the characteristic decrease in exci-
mer and increase in monomer emission, which is indicative
of dilution of the pyrene-labeled lipid, rather than a con-
sequence of protein binding. No transfer of pyrene lipids was
observed when CL was removed from the donor and accep-
tor vesicles by using POPC/POPE/POPG (1:1:1) with either
uMtCK or NDPK-D (data not shown).
Change in vesicle size as measured by QUELS
QUELS is a phenomenon that is dependent on the rate of
diffusion of the particles that scatter light. It is dependent on
the size and state of aggregation of vesicles. We observe
initially a slower, gradual increase in the size of the liposome
aggregates over the ﬁrst 6 min. Thereafter, a split into two
vesicle populations becomes apparent, with the reappearance
of small vesicles, similar in size to the original liposomes,
and a fraction of large vesicles even further increasing in size
(Fig. 7). This time-course is the result of initial protein-
induced bridging of vesicles, followed by a partial dissoci-
ation of octameric uMtCK into the dimeric form that no
longer can bridge the liposomes (28).
With NDPK-D (Fig. 8), there is no reversal in the size of
the liposomes. Aggregation to particles of ;300-nm diam-
eter (vesicle dimers) occurs rapidly and does not increase
greatly with time, although at longer times of 70 min the
major population increases in size to 500–600 nm and there
is a small fraction of very large aggregates. There is little
difference in the state of aggregation in the presence (Fig.
8 A) or absence (Fig. 8 B) of divalent cations.
DISCUSSION
Both protein kinases, uMtCK and NDPK-D, exhibited the
ability to accelerate the dilution of labeled lipids from donor
to acceptor liposomes. We have demonstrated this phenom-
enon by several alternative methods including the transfer of
BODIPY-FL-C5-HPC, of R18 lipid and of pyrene-labeled
lipids. All of these assays showed similar effects, indicating
that the phenomenon is not sensitive to the nature of the ﬂuo-
rescent amphiphile used. These assays by themselves do not
reveal the mechanism by which transfer of lipid occurs. It
could be a consequence of fusion, hemifusion, collapse of
vesicle morphology, or lipid transfer. However, additional
assays (membrane fusion, leakage, and QUELS) indicate
that the lipid probes are diluted into acceptor vesicles by lipid
transfer. The only proteins known to enhance this process are
speciﬁc lipid transfer proteins, except for t-Bid, which is
suggested to resemble a lipid transfer protein (15). In addi-
tion, the process is speciﬁc for the oligomeric forms of uMtCK
and NDPK-D that can bridge membranes and does not occur
with dimeric uMtCK or with the basic mitochondrial protein,
cytochrome c.
Notably, lipid dilution via lipid transfer is supported by the
absence of membrane fusion in the NBD-PE/Rh-PE FRET
FIGURE 7 QUELS analysis of liposome size distribution after addition of
120 nM uMtCK to donor and acceptor LUVs of POPC/POPE/CL (1:1:1) in
HEPES-Ca21 buffer pH 6.9, together with 1 mM Mg21. (1) LUVs. (2) One
min after protein addition. (3) Six min after protein addition. (4) Eight min
after protein addition. (5) 10 min after protein addition. (6) 22 min after
protein addition. Note that the scales on the abscissa are not all the same, nor
are they aligned.
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assay. If lipid dilution would occur via membrane fusion or
hemifusion, it should just depend on protein-induced forma-
tion of newmorphologies, and not on properties of the applied
probe as in our assays. A large degree of membrane fusion is
also excluded by the QUELS assays. Small vesicles compa-
rable in size to the original donor vesicles reappear from larger
aggregates after dissociation of octameric uMtCK into dimers
in dilute solution (Fig. 7). This would not occur if fusion had
taken place, although it does not exclude the possibility that
there is some percentage of fusion.
Lipid transfer between the twomitochondrialmembranes is
known in cells. Cardiolipin is synthesized on themitochondrial
inner membrane (63) but moves to the surface of mitochondria
early in apoptosis (17). This ﬁnally leads to transfer of
cardiolipin to other membranes in the cell (64). Such transfer
likely happens at contact sites where cardiolipin is enriched
(46) and where part of uMtCK and NDPK-D are located (8).
The bridging of the two membranes by these proteins can be
explained by their common feature of exposing identical top
and bottom faces, which speciﬁcally bind to lipid membranes,
preferentially to those containing cardiolipin; this brings these
membranes into close proximity where they can participate in
lipid transfer. The biological importance of this lipid transfer is
shown by the fact that a promyelocytic leukemia cell line that
exhibits somewhat less exposure of cardiolipin is resistant to
apoptosis (16). Hence, there is a clear association between
apoptosis and the exposure of cardiolipin on the surface of
mitochondria. In addition, tumor cells that are poorly differ-
entiated have fewer contact sites (65). Such cells are also more
resistant to apoptosis (66), again suggesting a relationship
between apoptosis and the presence of contact sites where the
proteins we are studying are known to be located.
The conditions used in these liposomal assays mimic many
of the properties one would ﬁnd in mitochondria. The pH and
ionic strength of these assays is similar to that found in
mitochondria. It is known that the pH in the intermembrane
space in mitochondria is 0.2–0.6 units below that in the
cytosol and thus similar to the pH 6.9 that we used, as is the
ionic strength,which is 100–150mMboth in our assays and in
mitochondria (67). The lipid composition of our liposomes
are similar to that found with isolated mitochondrial contact
sites (46). Liposomes can be bridged by addition of MtCK or
NDPK-D similar to the process leading to contact sites in
mitochondria. The mechanism of lipid transfer may be
analogous to the one demonstrated with myelin basic protein
(59). There is some speciﬁcity in the lipid transfer carried out
by uMtCK in that pyrene-PC is not transferred. This is in
accordwith the fact that this enzyme does not bind to PC alone
(29).As compared to the oligomeric kinases,monomeric cyto-
chrome c also binds to CL-rich membranes and is enriched in
contact sites, but it does not promote lipid transfer because it
cannot bridge two membranes.
Although an anionic membrane is required to bind to the
cationic residues near the C-terminus of uMtCK, the require-
ment for CL is not solely on the basis of its charge. CL carries
approximately one negative charge at neutral pH (68,69), yet
another anionic lipid, phosphatidylglycerol, cannot replace
CL. Furthermore, CL binding of uMtCK is necessary but not
sufﬁcient for lipid transfer. Although 16% CL in the mem-
brane is sufﬁcient for uMtCK to bind (29), the fraction of CL
in the membrane has to be.16% to promote lipid transfer in
liposomes.
A marked difference between CL and PG is the greater
tendency of CL to form nonlamellar phases. It is known that
FIGURE 8 QUELS analysis of lipo-
some size distribution: after addition of
100 nM NDPK-D to donor and accep-
tor LUVs of POPC/POPE/CL (1:1:1).
(Top curve) The LUVs were made in
HEPES-Ca21 pH 6.9 and showed no
change in size in the presence or
absence of added Mg21. No protein
added. (A) In HEPES-Ca21 pH 6.9
buffer. (B) In 10 mM HEPES, 0.1 mM
EDTA, 0.14 M NaCl, pH 6.9. (1) Five
min after protein addition. (2) 10 min
after protein addition. (3) 70 min after
protein addition. Note that the scales on
the abscissa are not all the same, nor are
they aligned.
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when CL loses its negative charge it does not form stable
bilayers. However, in this study, no hexagonal phases are
formed, as indicated by the lack of liposome contents leakage
aswell as frommicroscopy studies usingGUVs that show that
the vesicle morphology is retained in the presence of protein.
In addition, it has been shown that bilayers of PG are less
readily dehydrated by proteins than those of CL (70). The
binding of MtCK to the membrane changes the interfacial
properties, asmeasured by theﬂuorescent probeLaurdan (30),
in amanner consistent with the protein causing dehydration of
the membrane surface.Membrane dehydration is often accom-
panied by rigidiﬁcation of the membrane (71). It is possible
that binding of these mitochondrial proteins to CL-rich mem-
branes induces loss of interfacial water and allowsmore facile
lipid transfer if there are two juxtaposed bilayers. Such a
mechanism would be very different from that of lipid transfer
proteins that bind to lipids.
The structures of uMtCK and NDPK-D do not contain
features such as hydrophobic segments or sequence homol-
ogywith lipid transfer proteins thatwould necessarily indicate
that they function as lipid transfer proteins. However, there is
a stretch of some hydrophobic residues in the C-terminal
phospholipid-binding domain of MtCK, which could perturb
lipid organization or partially penetrate the bilayer (5,20).
Furthermore, except for their oligomeric structures and their
capability to bind to and to crosslink membranes containing
anionic phospholipids, these two proteins are unrelated, yet
both can function to promote lipid transfer. uMtCK and
NDPK-D have in common that they associate into highly
symmetrical oligomeric entities with identical top and bottom
faces that are able to interact with and cross-link membranes.
It is this structural arrangement, as well as the effects of these
proteins onmembrane properties that result in thembeing able
to promote the transfer of lipids. Nevertheless, these protein
oligomers do not allow the bilayers to come into direct contact
and it is not clear what path the lipid takes to traverse the
length of the protein oligomer. This is an issue under current
investigation.
Finally, there is potential for a regulation of the lipid
transfer rate between mitochondrial membranes by these
kinases. The dimeric form of uMtCK is not active in lipid
transfer and cannot bridge two membranes. Thus, any change
in the octamer/dimer ratio would affect lipid transfer. With
NDPK-D, the level of expression varies considerably among
different cell types and may provide another mechanism of
regulation. The interbilayer movement of lipid in mitochon-
dria likely has several functional consequences, amongwhich
is apoptotic signaling. For example, exposure of CL at the
mitochondrial surface can promote apoptosis (18). Further-
more, uMtCK is downregulated in oral squamous cell carci-
noma (72) possibly making these cells more resistant to
apoptosis.
uMtCK and NDPK-D are also present at contact sites in
cells not undergoing apoptosis, yet little cardiolipin is trans-
located to the mitochondrial surface. A small amount of
cardiolipin is possibly associated with proteins at contact sites
of the outer membrane, but difﬁcult to detect. However, for
such cardiolipin translocation in vivo, one has to consider the
net ﬂux of cardiolipin, which is a result of the balance of
several processes. There is a mechanism for the rapid inward
movement of lipids in mitochondria (73), and a mitochondrial
lipid scramblase is also known to promote the redistribution of
lipids betweenmitochondrial membranes (74). Thus, there are
multiple pathways for the movement of lipid between mito-
chondrial membranes and the relative importance of each of
these will depend on the expression level of the relevant
proteins, as well as on the regulation of their lipid transfer
activity, e.g., by factors like mitochondrial calcium. It is in-
teresting in this context that the substrate of MtCK, creatine,
signiﬁcantly protects the mitochondrial permeability transi-
tion pore against opening, a trigger of apoptosis induction by
mitochondria (see (75)). As already stated above, in apoptosis
there must be a change in the balance of rates among all lipid
transfer processes to favor net outward movement of cardio-
lipin. The novel, rather striking function of MtCK (ubiquitous
and sarcomeric) and NDPK-D, in being capable of mediating
lipid transfer between two membranes has been demonstrated
in vitro. Elucidation of its contribution in vivo and its detailed
mechanism will be a challenge for future experiment.
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